RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Cresset Asset Management, LLC's Holding History (CIK: 0001761013)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 39,237 Value ($000) $160 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 39,288 Value ($000) $192 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 24,163 Value ($000) $122 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 24,877 Value ($000) $132 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 25,029 Value ($000) $169 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 70,692 Value ($000) $466 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 73,352 Value ($000) $550 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 63,561 Value ($000) $634 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 52,169 Value ($000) $514 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 15,077 Value ($000) $115 Avg Close $9.98 Range $6.44 - $16.75
Q4 2022
Shares 46,861 Value ($000) $361 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 46,861 Value ($000) $499 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 46,861 Value ($000) $381 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 47,017 Value ($000) $337 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 133,437 Value ($000) $2,286 Avg Close $18.82 Range $15.25 - $23.86